# TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine

> **NCT04671459** · PHASE2 · UNKNOWN · sponsor: **Prof. Franciszek Lukaszczyk Memorial Oncology Center** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Recurrent Glioblastoma

## Interventions

- **COMBINATION_PRODUCT:** TTFields and SRS

## Key facts

- **NCT ID:** NCT04671459
- **Lead sponsor:** Prof. Franciszek Lukaszczyk Memorial Oncology Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-26
- **Primary completion:** 2023-07-20
- **Final completion:** 2024-12-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04671459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04671459, "TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04671459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*